Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
0.9841
-0.0759 (-7.16%)
Mar 31, 2025, 1:40 PM EDT - Market open
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $60.61 million as of March 31, 2025. Its market cap has decreased by -74.43% in one year.
Market Cap
60.61M
Enterprise Value
-44.83M
1-Year Change
-74.43%
Ranking
Category
Stock Price
$0.98
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $60.61M, a decrease of -88.43%. That is a compound annual growth rate of -46.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 65.29M | -29.62% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 742.71B |
| UnitedHealth Group | 474.82B |
| Johnson & Johnson | 395.85B |
| AbbVie | 359.56B |
| Novo Nordisk | 308.71B |
| Abbott Laboratories | 229.02B |
| Merck & Co. | 226.23B |
| AstraZeneca | 225.00B |